Skip to main content

Phio Pharmaceuticals Corp

For the period ended Jun 30, 2024. Filed Aug 14, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 14, 2024

PHIO$0.80+0.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

INDEX

Part No.Item No.DescriptionPage No.
IFINANCIAL INFORMATION3
1Financial Statements (Unaudited)3
Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 20233
Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2024 and 20234
Condensed Consolidated Statements of Preferred Stock and Stockholders’ Equity for the Three and Six Months Ended June 30, 2024 and 20235
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2024 and 20236
Notes to Condensed Consolidated Financial Statements7
2Management’s Discussion and Analysis of Financial Condition and Results of Operations16
3Quantitative and Qualitative Disclosures About Market Risk22
4Controls and Procedures22
IIOTHER INFORMATION23
1Legal Proceedings23
1ARisk Factors23
2Unregistered Sales of Equity Securities and Use of Proceeds24
3Defaults Upon Senior Securities24
4Mine Safety Disclosures24
5Other Information24
6Exhibits25
Signatures26
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.